Synpac (North Carolina), Inc.
Records under this name other than the patents Synpac (North Carolina), Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 6 of 6 · Back to Synpac (North Carolina), Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,809,282 | A Method of Reducing Titers of Antibodies Specific for a Therapeutic Agent Lapsed on the fee record Ended Aug 19, 2026 · High confidence | Lapsed on the fee record | Ended Aug 19, 2026 | High confidence |
| US 7,056,712 | Treatment of Glycogen Storage Disease Type II Term ended Term ended Feb 26, 2023 · High confidence | Term ended | Term ended Feb 26, 2023 | High confidence |
| US 8,900,552 | Treatment of Glycogen Storage Disease Type II Term ended Term ended Jul 10, 2021 · Medium confidence | Term ended | Term ended Jul 10, 2021 | Medium confidence |
| US 9,370,556 | Treatment of Glycogen Storage Disease Type II Term ended Ended no later than Jul 10, 2021 · Low confidence | Term ended | Ended no later than Jul 10, 2021 | Low confidence |
| US 9,907,839 | Treatment of Glycogen Storage Disease Type II Term ended Term ended Jul 10, 2021 · Medium confidence | Term ended | Term ended Jul 10, 2021 | Medium confidence |
| US 10,792,341 | Treatment of Glycogen Storage Disease Type II Term ended Term ended Jul 10, 2021 · Medium confidence | Term ended | Term ended Jul 10, 2021 | Medium confidence |